BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Bioptigen Receives European Approval for Eye-Imaging Tool


12/19/2011 7:30:02 AM

Triangle Business Journal by Jason deBruyn, Staff Writer

Medical device company Bioptigen has received approval to market an eye-imaging tool in Europe.

Based in Research Triangle Park, Bioptigen focuses on devices to take detailed images of the eye. The company is a spinout from the Duke University Biomedical Engineering Department.

Sales projections were not publicly available. The company has raised about $7.5 million since 2005 through investors and grants. In a previous interview, Bioptigen President and CEO Eric Buckland said the private capital came primarily from angel investors.

“We are seeking to grow in the medical device space without the venture capital,” he said in November.

The approved device, the hand-held Envisu C2000-series, is intended for clinical use in the European Union.




Bioptigen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->